Monika E. Grabowska

Monika E. Grabowska

Auto-generated profile, based on publicly available information

Monika E. Grabowska

Department of Biomedical Informatics, Vanderbilt University Medical Center

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2024 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
CYChao Yan
Chao Yan
MGMonika E. Grabowska
Monika E. Grabowska
ADAlyson L. Dickson
Alyson L. Dickson
BLBingshan Li
Bingshan Li
ZWZhexing Wen
Zhexing Wen
WWWei-Qi Wei
Wei-Qi Wei
Drug repurposing represents an attractive alternative to the costly and time-consuming process of new drug development, particularly for serious, widespread conditions with limited effective treatments, such as Alzheimer’s disease (AD). Emerging generative artificial intelligence (GAI) technologies like ChatGPT offer the promise of expediting the review and summary of scientific knowledge. To examine the feasibility of using GAI for identifying drug repurposing candidates, we iteratively tasked ChatGPT with proposing the twenty most promising drugs for repurposing in AD, and tested the top ten for risk of incident AD in exposed and unexposed individuals over age 65 in two large clinical datasets: (1) Vanderbilt University Medical Center and (2) the All of Us Research Program. Among the candidates suggested by ChatGPT, metformin, simvastatin, and losartan were associated with lower AD risk in meta-analysis. These findings suggest GAI technologies can assimilate scientific insights from an extensive Internet-based search space, helping to prioritize drug repurposing candidates and facilitate the treatment of diseases.

1 December 2023 in Journal of the American Medical Informatics Association
Verified
Journal Article
Closed access
MGMonika E Grabowska
Monika E Grabowska
SDSara L Van Driest
Sara L Van Driest
JRJamie R Robinson
Jamie R Robinson
APAnna E Patrick
Anna E Patrick
CGChris Guardo
Chris Guardo
WWWei-Qi Wei
Wei-Qi Wei
Objective: Pediatric patients have different diseases and outcomes than adults; however, existing phecodes do not capture the distinctive pediatric spectrum of disease. We aim to develop specialized pediatric phecodes (Peds-Phecodes) to enable efficient, large-scale phenotypic analyses of pediatric patients. Materials and Methods: We adopted a hybrid data- and knowledge-driven approach leveraging electronic health records (EHRs) and genetic data from Vanderbilt University Medical Center to modify the most recent version of phecodes to better capture pediatric phenotypes. First, we compared the prevalence of patient diagnoses in pediatric and adult populations to identify disease phenotypes differentially affecting children and adults. We then used clinical domain knowledge to remove phecodes representing phenotypes unlikely to affect pediatric patients and create new phecodes for phenotypes relevant to the pediatric population. We further compared phenome-wide association study (PheWAS) outcomes replicating known pediatric genotype-phenotype associations between Peds-Phecodes and phecodes. Results: The Peds-Phecodes aggregate 15 533 ICD-9-CM codes and 82 949 ICD-10-CM codes into 2051 distinct phecodes. Peds-Phecodes replicated more known pediatric genotype-phenotype associations than phecodes (248 vs 192 out of 687 SNPs, P < .001). Discussion: We introduce Peds-Phecodes, a high-throughput EHR phenotyping tool tailored for use in pediatric populations. We successfully validated the Peds-Phecodes using genetic replication studies. Our findings also reveal the potential use of Peds-Phecodes in detecting novel genotype-phenotype associations for pediatric conditions. We expect that Peds-Phecodes will facilitate large-scale phenomic and genomic analyses in pediatric populations. Conclusion: Peds-Phecodes capture higher-quality pediatric phenotypes and deliver superior PheWAS outcomes compared to phecodes.

1 February 2022 in World Neurosurgery
Verified
Journal Article
Closed access
ABAskiel Bruno
Askiel Bruno
NPNina Paletta
Nina Paletta
UVUttam Verma
Uttam Verma
MGMonika E. Grabowska
Monika E. Grabowska
HHHeather M. Haughey
Heather M. Haughey
FNFenwick T. Nichols
Fenwick T. Nichols

21 February 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YXYi Xin
Yi Xin
MGMonika E. Grabowska
Monika E. Grabowska
SGSrushti Gangireddy
Srushti Gangireddy
MKMatthew S. Krantz
Matthew S. Krantz
VKVern Eric Kerchberger
Vern Eric Kerchberger
WWWei-Qi Wei
Wei-Qi Wei
Topic modeling utilizes unsupervised machine learning to detect underlying themes within texts and has been deployed routinely to analyze social media for insights into healthcare issues. However, the inherent messiness of social media hinders the full realization of this technique’s potential. As such, we hypothesized that restricting medical concepts in social media texts to specific related semantic types and applying topic modeling to these concepts could be a feasible approach to overcome the challenge of traditional topic modeling for social media texts. Therefore, we developed a semantic-type-based topic modeling pipeline to discover self-reported health-related topics. This pipeline integrated semantic type information and Systematized Medical Nomenclature for Medicine (SNOMED) precoordinated expressions into a traditional topic modeling approach to enhance effectiveness in clustering meaningful, distinct topics. Using social media texts regarding statins for illustration, we evaluated the efficacy of this new approach and validated a newly identified topic using real-world clinical data. Based on expert evaluations, this approach resulted in more novel, distinguishable, and meaningful health-related topics compared to traditional topic modeling. In addition, our electronic health record validation for a newly identified topic in two real-world clinical databases indicated that statin users had a higher prevalence of depression or anxiety compared to matched non-users. Our results indicate that this new topic modeling pipeline can improve the extraction of themes from noisy online discussions, thereby contributing to deeper insights for healthcare research.

1 July 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
ABAskiel Bruno
Askiel Bruno
NPNina Paletta
Nina Paletta
UVUttam Verma
Uttam Verma
MGMonika E. Grabowska
Monika E. Grabowska
PBPrem P. Batchala
Prem P. Batchala
FNFenwick T. Nichols
Fenwick T. Nichols

26 December 2024 in JAMIA Open
Verified
Journal Article
Open access
NWNicholas C Wan
Nicholas C Wan
MGMonika E Grabowska
Monika E Grabowska
VKVern Eric Kerchberger
Vern Eric Kerchberger
WWWei-Qi Wei
Wei-Qi Wei
Objective: The phenome-wide association study (PheWAS) systematically examines the phenotypic spectrum extracted from electronic health records (EHRs) to uncover correlations between phenotypes and exposures. This review explores methodologies, highlights challenges, and outlines future directions for EHR-driven PheWAS. Materials and Methods: We searched the PubMed database for articles spanning from 2010 to 2023, and we collected data regarding exposures, phenotypes, cohorts, terminologies, replication, and ancestry. Results: Our search yielded 690 articles. Following exclusion criteria, we identified 291 articles published between January 1, 2010, and December 31, 2023. A total number of 162 (55.6%) articles defined phenomes using phecodes, indicating that research is reliant on the organization of billing codes. Moreover, 72.8% of articles utilized exposures consisting of genetic data, and the majority (69.4%) of PheWAS lacked replication analyses. Discussion: Existing literature underscores the need for deeper phenotyping, variability in PheWAS exposure variables, and absence of replication in PheWAS. Current applications of PheWAS mainly focus on cardiovascular, metabolic, and endocrine phenotypes; thus, applications of PheWAS in uncommon diseases, which may lack structured data, remain largely understudied. Conclusions: With modern EHRs, future PheWAS should extend beyond diagnosis codes and consider additional data like clinical notes or medications to create comprehensive phenotype profiles that consider severity, temporality, risk, and ancestry. Furthermore, data interoperability initiatives may help mitigate the paucity of PheWAS replication analyses. With the growing availability of data in EHR, PheWAS will remain a powerful tool in precision medicine.